Results: 443

For: Treatment

Dose equivalents of antidepressants: standardising prescribing between different drugs

shutterstock_125648294

Andrew Shepherd summarises a meta-analysis, which looks at the dose equivalents of antidepressants by bringing together data from 83 trials of 23 different antidepressants.

[read the full story...]

Trauma-focused psychotherapies for PTSD in people with experiences of psychosis: A change in the status quo?

shutterstock_87407252

Clinical Psychologist and Researcher Rachel Brand publishes her debut blog on a recent RCT of Prolonged Esposure vs Eye Movement Desensitization and Reprocessing vs Waiting List for patients with PTSD and psychosis.

[read the full story...]

The evidence for mindfulness: Mental Health Awareness Week #mhaw15

eld_themed_header

Mental Health Awareness Week starts today! It’s all about mindfulness this year, so we are showing our support by highlighting the evidence-based blogs we’ve written on the subject over the last few years. Start here if you want to read about the evidence for mindfulness, mindfulness-based cognitive therapy and mindfulness-based group therapy.

[read the full story...]

Pharmacotherapy for PTSD: an update on the evidence finds some efficacy but small effect sizes

shutterstock_226105741

Patrick Kennedy-Williams summarises a recent systematic review of pharmacotherapy for PTSD, which compares antidepressants with placebo for post-traumatic stress disorder. [Please note: this blog was amended on 7/5/15].

[read the full story...]

Motivational interviewing may help people quit smoking, but more research is needed

shutterstock_112912876

Olivia Maynard summarises the recent Cochrane systematic review on motivational interviewing for smoking cessation, which concludes that motivational interviewing may assist people to quit smoking, but does not tell us much about the actual components of MI that optimise the success of the intervention.

[read the full story...]

The more psychotic you are, the more benefit there is in taking antipsychotics

shutterstock_122223547

John Baker reviews a recent participant-level meta-analysis of six placebo-controlled studies, which looks at the initial severity of schizophrenia and the efficacy of antipsychotics including Olanzapine, Risperidone and Amisulpride.

[read the full story...]

Another negative trial of cognitive bias modification: a case for Occam’s razor

William of Ockham

Ioana Cristea reviews a recent RCT that found no effects of positive imagery-based cognitive bias modification, delivered as a web-based treatment for people with depression.

[read the full story...]

Mindfulness-based cognitive therapy to prevent depression

shutterstock_206726899

André Tomlin presents the results of the PREVENT RCT published today in The Lancet, which investigates the effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence.

[read the full story...]

The antidepressant effects of ketamine are confirmed by a new systematic review and meta-analysis

shutterstock_18453376

Helge Hasselmann summarises a new systematic review and meta-analysis, which confirms the antidepressant effects of ketamine.

[read the full story...]